
One Health Group plc
("One Health", the "Company" or the "Group")
Full Year Trading Update
FY 26 revenue and underlying EBITDA ahead of market expectations
Strong growth across all KPIs
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', provides the following trading update for the year ended 31 March 2026 ("FY 26"), showing continued growth, ahead of market expectations.1
Key Highlights
|
|
FY 26
|
FY 25
|
Growth
|
|
Revenue |
£32.0m |
£28.4m |
13% |
|
New NHS patient referrals |
18,931 |
17,020 |
11% |
|
Number of consultations |
50,774 |
42,238 |
20% |
|
Number of surgical procedures |
8,113 |
7,043 |
15% |
|
Number of consultants (excluding anaesthetists) |
88 |
80 |
10% |
|
Number of Outreach Clinics |
40 |
37 |
8% |
|
Number of Surgical Operating Facilities |
14 |
10 |
40% |
Surgical Hub progress
· As announced on 23 February, construction of the Company's first Surgical Hub in Scunthorpe, Lincolnshire, has commenced
· The project is on track to be delivered within the one-year construction period and in line with the previous cost estimate of £8m to £9m
· Further locations in underserved areas with high NHS demand continue to be explored for preliminary assessment of suitability for future surgical hubs
Outlook
The Board is confident in the Company's strategy to drive continued organic growth through increased patient referrals, a strong pipeline of new surgeons, and additional surgical capacity in existing and new independent sector hospitals. The Company continues to support the delivery of the challenging NHS waiting list reduction targets set by the Government.
The Company is expected to deliver growth at the revenue and underlying EBITDA levels for FY 26, ahead of market expectations1. Cash at 31 March 2026 was £11.1m (FY 25: £11.4m) with the Company remaining well-funded to deliver further organic growth and execute the carefully planned delivery of the Group's first surgical hub to accelerate growth and improve profitability.
1Management understands consensus market estimates for revenue and underlying EBITDA for FY 26 to be £29.4 million and £2.3 million respectively.
Adam Binns, Chief Executive Officer, commented:
"We are delighted to deliver a strong year end trading update ahead of market expectations for our first full year following our AIM listing and that construction of our first surgical hub commenced during this period. NHS national waiting lists remain very high, despite continued NHS efforts and recent modest reductions, and we are proud that One Health remains well-positioned to continue to reduce pressure on the NHS by providing free high-quality care across underserved areas."
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
This announcement contains inside information for the purposes of the UK Market Abuse Regulation
and the Directors of the Company are responsible for the release of this announcement.
For more information, please contact:
|
One Health Group plc Derek Bickerstaff, Chairman Adam Binns, CEO
|
Via Walbrook PR |
|
|
Panmure Liberum (Nominated Adviser and Broker) Emma Earl, Will Goode, Mark Rogers Rupert Dearden
|
Tel: +44 (0)20 3100 2000 |
|
|
Walbrook PR (Media & Investor Relations) Alice Woodings / Paul McManus / Rachel Broad |
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 / +44 (0)7747 515 393 |
|
|
|
||
About One Health Group plc (www.onehealth.co.uk)
One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to 18,931 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
